These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 39325128)

  • 41. Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice.
    Steri V; Ellison TS; Gontarczyk AM; Weilbaecher K; Schneider JG; Edwards D; Fruttiger M; Hodivala-Dilke KM; Robinson SD
    Circ Res; 2014 Jan; 114(1):79-91. PubMed ID: 24103390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beyond Angiogenesis: Exploiting Angiocrine Factors to Restrict Tumor Progression and Metastasis.
    Singhal M; Augustin HG
    Cancer Res; 2020 Feb; 80(4):659-662. PubMed ID: 31831463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis.
    Cui X; Morales RT; Qian W; Wang H; Gagner JP; Dolgalev I; Placantonakis D; Zagzag D; Cimmino L; Snuderl M; Lam RHW; Chen W
    Biomaterials; 2018 Apr; 161():164-178. PubMed ID: 29421553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis.
    Liang W; Ferrara N
    Cancer Immunol Res; 2016 Feb; 4(2):83-91. PubMed ID: 26839309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immune therapy and tumor angiogenesis].
    Takakura N
    Rinsho Ketsueki; 2020; 61(9):1440-1445. PubMed ID: 33162547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity.
    Wang JX; Choi SYC; Niu X; Kang N; Xue H; Killam J; Wang Y
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma.
    Zhang L; Xu J; Zhou S; Yao F; Zhang R; You W; Dai J; Yu K; Zhang Y; Baheti T; Pu L; Xu J; Qian X; Zhang C; Xia Y; Dai X; Li Q; Wang X
    J Hepatol; 2024 Jan; 80(1):82-98. PubMed ID: 37838036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stromal Cells in the Tumor Microenvironment.
    Denton AE; Roberts EW; Fearon DT
    Adv Exp Med Biol; 2018; 1060():99-114. PubMed ID: 30155624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.
    Purhonen S; Palm J; Rossi D; Kaskenpää N; Rajantie I; Ylä-Herttuala S; Alitalo K; Weissman IL; Salven P
    Proc Natl Acad Sci U S A; 2008 May; 105(18):6620-5. PubMed ID: 18443294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-angiogenesis: making the tumor vulnerable to the immune system.
    Griffioen AW
    Cancer Immunol Immunother; 2008 Oct; 57(10):1553-8. PubMed ID: 18438662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of vascular endothelial cells in tumor metastasis.
    Feng Y; Luo S; Fan D; Guo X; Ma S
    Acta Histochem; 2023 Aug; 125(6):152070. PubMed ID: 37348328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.
    Shenoy AK; Lu J
    Cancer Lett; 2016 Oct; 380(2):534-544. PubMed ID: 25449784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphatic endothelial cells support tumor growth in breast cancer.
    Lee E; Pandey NB; Popel AS
    Sci Rep; 2014 Jul; 4():5853. PubMed ID: 25068296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mobilization, recruitment and contribution of bone marrow-derived endothelial progenitor cells to the tumor neovascularization occur at an early stage and throughout the entire process of hepatocellular carcinoma growth.
    Zhu H; Shao Q; Sun X; Deng Z; Yuan X; Yu D; Zhou X; Ding Y
    Oncol Rep; 2012 Oct; 28(4):1217-24. PubMed ID: 22858892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.
    Png KJ; Halberg N; Yoshida M; Tavazoie SF
    Nature; 2011 Dec; 481(7380):190-4. PubMed ID: 22170610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD40-induced countercurrent conduits for tumor escape or elimination?
    Murugaiyan G; Martin S; Saha B
    Trends Immunol; 2007 Nov; 28(11):467-73. PubMed ID: 17981086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells.
    Chouaib S; Kieda C; Benlalam H; Noman MZ; Mami-Chouaib F; Rüegg C
    Crit Rev Immunol; 2010; 30(6):529-45. PubMed ID: 21175416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
    Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneity of endothelial cells--role in vessel specialization and cooperation in vasculogenic mimicry.
    Kieda C
    Postepy Biochem; 2013; 59(4):372-8. PubMed ID: 24745167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The heterogeneity of cancer endothelium: The relevance of angiogenesis and endothelial progenitor cells in cancer microenvironment.
    Armani G; Pozzi E; Pagani A; Porta C; Rizzo M; Cicognini D; Rovati B; Moccia F; Pedrazzoli P; Ferraris E
    Microvasc Res; 2021 Nov; 138():104189. PubMed ID: 34062191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.